$20 million facility investment from SEM Biotech
The manufacturer of vacuum blood collection systems is taking steps to grow in the global healthcare market with its new investment.
SEM Biotech, operating in the field of vacuum blood collection systems, aims for strong growth in the global healthcare market with its production facility brought to life through a $20 million investment.
Global Market Target
Operating in the vacuum blood collection systems sector, SEM Biotech aims to have a greater say internationally with its new production facility investment.
Thanks to this strategic move, the company aims to achieve permanent growth in global healthcare markets.
International Congress Support
In line with its goals in the global market, SEM Biotech supported a major event held in Istanbul between September 9-13.
The company provided official sponsorship support for the XXIII. World Congress of Oto-Rhino-Laryngology Head and Neck Surgery, IFOS Istanbul 2026 organization.
Statements from the Board of Directors
SEM Biotech Founder and Chairman of the Board Yavuz Eroğlu made evaluations regarding the company's founding vision and goals.
Yavuz Eroğlu emphasized that the brand does not focus solely on the domestic market, but aims to be a technology brand that will gain trust even in the world's most selective healthcare markets.